medicin
plant
wide
use
treat
varieti
infecti
noninfecti
ailment
accord
one
estim
commonli
use
medicin
contain
compound
isol
plant
sever
plant
could
offer
rich
reserv
drug
discoveri
infecti
diseas
particularli
era
latest
separ
techniqu
avail
one
hand
human
popul
challeng
number
emerg
infecti
diseas
hand
among
sever
ailment
viral
infect
particularli
infect
associ
human
immunodefici
viru
type
newli
emerg
infecti
virus
challeng
mankind
surviv
import
varieti
medicin
plant
shown
promis
treat
number
viral
infect
possess
broadspectrum
antivir
activ
past
explor
antivir
activ
variou
promis
medicin
plant
limit
due
highli
infecti
natur
virus
b
lack
appropri
separ
techniqu
identif
antivir
compon
plant
develop
vectorbas
strategi
noninfecti
molecular
clone
viru
could
use
antivir
screen
purpos
advanc
separ
technolog
offer
promis
medicin
plant
usag
modern
drug
discoveri
articl
describ
potenti
antivir
properti
medicin
plant
divers
group
virus
suggest
screen
potenti
plant
possess
broadspectrum
antivir
effect
emerg
viral
infect
histori
medicin
plant
date
back
origin
human
civil
earth
sever
may
use
treat
viral
infect
past
howev
first
recogn
interest
develop
antivir
agent
effort
boot
drug
compani
nottingham
england
screen
plant
antiinfluenza
activ
chantril
et
al
later
studi
report
inhibitori
effect
medicin
plant
extract
replic
sever
virus
particularli
herp
simplex
viru
type
debiaggi
et
al
hiv
asr
bucar
vermani
garg
hepat
b
viru
hbv
kwon
et
al
emerg
viral
infect
associ
poxviru
sever
acut
respiratori
syndrom
sar
viru
kotwal
et
al
strongli
inhibit
variou
plant
extract
studi
util
either
water
solubl
alcohol
extract
medicin
plant
limit
effort
direct
toward
identif
activ
natur
ingredi
exhibit
antivir
effect
moreov
recent
studi
show
antivir
potenti
plant
extract
viral
strain
resist
convent
antivir
agent
serkedjieva
tolo
et
al
challeng
modern
drug
discoveri
practic
deem
care
look
toward
explor
natur
antivir
compon
medicin
plant
molecular
mechan
associ
antivir
effect
plant
extract
may
vari
among
differ
virus
howev
potenti
plant
extract
boost
inher
antivir
defens
human
bodi
involv
intric
immun
system
might
util
common
pathway
recent
past
number
studi
explor
immunostimulatori
properti
plant
extract
antivir
properti
webster
et
al
root
extract
medicin
plant
heracleum
maximum
bartr
umbellifera
possess
antivir
effect
besid
antifung
antibacteri
properti
stimul
interleukin
product
macrophag
activ
assay
confirm
antivir
effect
associ
immunostimulatori
properti
webster
et
al
furthermor
plantago
major
linn
p
asiatica
linn
plantaginacea
commonli
use
plant
folk
medicin
taiwan
treatment
infecti
diseas
exhibit
lymphocyt
prolifer
secret
interferongamma
low
concentr
lymphocyt
prolifer
activ
induc
secret
interferongamma
indic
cellmedi
immun
respons
modul
chiang
et
al
along
similar
line
sambucol
product
isol
sambucu
nigra
l
effect
variou
strain
influenza
shown
boost
immun
respons
secret
inflammatori
cytokin
beta
tnfalpha
barak
et
al
besid
immunomodulatori
effect
anoth
intrigu
find
broadspectrum
antivir
natur
plant
extract
pompei
et
al
could
associ
singl
phytochem
number
differ
plant
constitu
among
sever
observ
extract
trifollium
speci
secometv
exhibit
antivir
effect
number
infecti
virus
human
papillomaviru
marburg
influenza
hiv
hbv
hcv
kotwal
et
al
ii
pandanin
lectin
isol
salin
extract
leav
pandanu
amaryllifoliu
roxb
show
antivir
effect
influenza
viru
strain
ooi
et
al
iii
crude
extract
hop
show
antivir
effect
divers
group
virus
suggest
presenc
broadspectrum
antivir
phytochem
variou
part
plant
buckwold
et
al
medicin
plant
use
throughout
world
howev
wide
usag
limit
china
india
japan
pakistan
sri
lanka
thailand
number
african
countri
detail
review
previous
describ
nation
activ
around
globe
relev
medicin
plant
usag
prioriti
hoareau
dasilva
develop
countri
also
turn
encourag
usag
plantbas
natur
medicin
product
healthcar
system
natur
health
product
regul
canada
promulg
januari
import
step
toward
modern
plantbas
product
usag
healthcar
regul
encourag
usag
modern
technolog
evidencebas
scientif
support
toward
promot
medicin
plant
associ
product
siow
et
al
tabl
tolo
et
al
phyllanthu
urinaria
l
geraniin
isol
phyllanthu
urinaria
inhibit
respect
yang
et
al
influenza
viru
geranium
sanguineum
l
medicin
plant
reduc
infect
variou
influenza
viru
strain
vitro
vivo
pantev
et
al
serkedjieva
random
doubleblind
placebocontrol
studi
reveal
elderberri
extract
seem
offer
effici
safe
costeffect
treatment
influenza
aqueou
extract
neem
leav
inhibit
vitro
vivo
parida
et
al
anecdot
lack
scientif
valid
moreov
lack
qualifi
personnel
field
medicin
plant
appropri
clinic
trial
also
necessari
valid
medicin
usag
plant
among
human
cati
practic
guid
herbal
therapi
peopl
live
hiv
good
start
highlight
potenti
phytochem
extract
plant
explor
identif
natur
product
control
hiv
associ
infect
necessari
due
sever
reason
first
effort
past
find
effect
cure
hiv
infect
met
disappoint
result
second
develop
vaccin
hiv
pandem
seem
farfetch
dream
effect
therapeut
regimen
hivinfect
individu
highli
activ
antiretrovir
therapi
haart
combin
proteas
inhibitor
nucleosid
nonnucleosid
revers
transcriptas
inhibitor
haart
control
hiv
infect
among
individu
continu
therapeut
regimen
withdraw
medic
lead
reemerg
diseas
furthermor
base
hiv
pathogenesi
effort
made
target
everi
step
viral
life
cycl
start
entri
viral
morphogenesi
shown
fig
howev
none
strategi
led
cure
plant
kingdom
highli
divers
rang
unicellular
microscop
plant
longliv
huge
tree
screen
everi
plant
individu
part
stem
leav
root
flower
bark
identif
antivir
compon
imposs
current
knowledg
relev
antivir
properti
medicin
plant
base
subject
inform
also
exampl
antivir
properti
plant
phytochem
screen
product
base
properti
newli
identifi
phytocompon
one
exampl
potenti
antivir
compound
cyanovirin
n
cvn
protein
isol
cyanobacterium
nostoc
ellipsosporum
cvn
possess
broadspectrum
antivir
activ
besid
inhibit
infect
boyd
et
al
list
potenti
emerg
antivir
compound
de
clercq
witvrouw
et
al
antivir
activ
cvn
dissect
molecular
level
involv
highli
specif
interact
viral
envelop
glycoprotein
barriento
et
al
esser
et
al
viral
envelop
play
major
role
infect
permiss
cell
mediat
interact
permiss
cell
receptor
concert
chemokin
receptor
also
class
antivir
compound
known
hiv
entri
inhibitor
fu
et
al
kostova
woradulayapinij
et
al
medicin
plant
also
shown
inhibitori
effect
viral
proteas
pr
enzym
essenti
proteolyt
process
polyprotein
precursor
protein
essenti
assembl
viral
particl
import
haart
favor
therapeut
regimen
treat
hivinfect
individu
also
contain
proteas
inhibitor
part
combin
drug
cocktail
past
phytochem
triterpen
deriv
number
medicin
plant
shown
inhibitori
effect
pr
huang
chen
hussein
et
al
park
et
al
yu
et
al
yu
et
al
ongo
effort
crucial
toward
develop
previous
character
proteas
inhibitor
identif
new
compound
activ
natur
occur
rt
proteas
inhibitor
variou
medicin
plant
also
offer
reserv
unexplor
antivir
compound
sever
member
human
herpesvirus
hhv
famili
caus
agent
human
diseas
major
hhv
infect
associ
member
herpesvirus
caus
differ
ill
varicella
zoster
viru
epstein
barr
viru
cytomegaloviru
past
medicin
plant
explor
singl
member
herp
famili
ie
hsv
exampl
aqueou
extract
plant
materi
use
treat
hsvassoci
infect
phytochem
podophyllotoxin
isol
aqueou
extract
podophyllum
peltatum
l
inhibit
hsv
type
bedow
hatfield
besid
aqueou
extract
organ
solvent
extract
variou
plant
also
shown
antihsv
activ
suggest
vari
natur
antivir
present
medicin
plant
two
compound
name
geraniin
isol
aceton
extract
anoth
plant
phyllanthu
urinaria
also
suppress
yang
et
al
hsv
infect
usual
seriou
problem
among
immunocompromis
individu
particularli
hivinfect
individu
moreov
develop
resist
herp
strain
refractori
convent
antivir
drug
also
major
issu
alway
quest
antivir
overcom
resist
strain
virus
suppress
emerg
viral
resist
base
avail
inform
one
easili
specul
presenc
natur
antivir
compound
effect
resist
strain
virus
one
preced
aqueou
extract
root
carissa
eduli
forssk
vahl
apocynacea
medicin
plant
local
grow
kenya
show
remark
antihsv
activ
vitro
vivo
wild
type
resist
strain
hsv
tolo
et
al
quest
influenza
viru
natur
inhibitor
ancient
past
centuri
sever
scientif
effort
direct
toward
identifi
phytochem
capabl
inhibit
influenza
viru
cochran
et
al
may
willuhn
studi
past
recent
literatur
suggest
varieti
natur
product
isol
sever
plant
inhibit
influenza
viru
vitro
mothana
et
al
pantev
et
al
prajoubklang
et
al
vivo
ivanova
et
al
prahoveanu
et
al
intrigu
observ
presenc
antiinfluenza
activ
wide
varieti
phytochem
alkaloid
flavonoid
glucosid
polyphenol
saponin
wang
et
al
hope
near
futur
abl
see
effect
phytochem
control
influenza
viru
although
exposur
virus
lead
acut
infect
howev
type
b
c
uniqu
caus
chronic
infect
tradit
medicin
viral
hepat
mainli
focus
plant
belong
genu
phyllanthu
euphorbiacea
famili
clinic
studi
also
design
compar
antihepat
b
effect
differ
speci
phyllanthu
ie
p
amaru
l
p
niruri
l
p
urinaria
l
wang
et
al
molecular
studi
antivir
potenti
p
amaru
l
show
inhibitori
effect
hbv
polymeras
activ
mrna
transcript
due
interact
hbv
enhanc
cebp
alpha
beta
transcript
factor
lee
et
al
ott
et
al
microarray
analys
reveal
antihbv
activ
ethanol
extract
anoth
member
phyllanthu
p
nanu
due
express
sever
gene
particularli
annexin
usual
screen
antivir
compound
snag
due
lack
repres
smaller
anim
model
howev
case
hbv
infect
human
duck
hepat
b
viru
dhbv
model
serv
excel
screen
system
niu
et
al
dhbv
system
use
screen
antihbv
effect
variou
medicin
plant
base
previou
observ
suggest
antihbv
effect
phyllanthu
speci
variou
member
plant
famili
screen
antivir
effect
dhbv
model
initi
find
reveal
phyllanthu
amaru
signific
inhibitori
effect
dhbv
dna
replic
vivo
niu
et
al
studi
compar
antivir
activ
p
amaru
p
madera
munshi
et
al
p
maderaspatensi
munshi
et
al
dhbv
model
conclud
medicin
plant
therapeut
potenti
hbv
human
previous
thought
although
p
nanu
anoth
member
phyllanthu
genu
plant
show
strong
inhibitori
effect
control
dhbv
primari
cell
cultur
model
controversi
data
need
investig
molecular
level
valid
initi
clinic
data
dhbv
model
besid
resolv
initi
observ
relev
therapeut
develop
phyllanthu
speci
plant
dhbv
model
help
identifi
number
plant
could
potenti
util
isol
candid
therapeut
appropri
clinic
trial
exampl
screen
differ
chines
medicin
herb
led
identif
two
potenti
antidhbv
plant
extract
ie
ardisia
chinensi
pithecellobium
clypearia
identif
antihbv
potenti
oenanth
javanica
blume
dc
flavon
ojf
strong
inhibitor
hbsag
hbeag
secret
involv
viral
pathogenesi
cell
reduc
dhbvdna
level
hbvinfect
duck
model
also
credit
valuabl
model
sometim
sever
medicin
plant
mix
togeth
develop
combin
therapi
treat
particular
ailment
viral
hepat
combin
therapi
also
tri
exampl
liquid
ferment
broth
ganoderma
lucidum
supplement
aqueou
extract
radix
sophora
flavescenti
chines
herbal
medicin
show
strong
antihepat
b
viru
activ
vitro
vivo
furthermor
coferment
medicin
plant
develop
antivir
broth
show
superior
antivir
effect
compar
simpl
mix
hepat
c
anoth
member
virus
caus
viral
hepat
studi
review
benefici
advers
effect
herbal
prepar
use
treatment
viral
hepat
cochran
collabor
medlin
embas
biosi
databas
data
manual
search
five
chines
one
japanes
journal
also
includ
besid
inform
random
clinic
trial
liu
et
al
evalu
previous
complet
random
trial
analysi
includ
studi
show
four
appropri
methodolog
disappointingli
herbsphytochem
use
clinic
trial
antihcv
activ
like
silybin
oxymatrin
show
signific
reduct
serum
aspart
aminotransferas
ast
gamma
glutamyltranspeptidas
level
hcv
clearanc
respect
number
chines
herbal
mix
bing
gan
tang
yi
zhu
decoct
yi
er
gan
tang
individu
combin
antivir
show
benefici
effect
clear
hcv
rna
normal
serum
alanin
aminotransferas
alt
variou
herbal
product
advers
event
also
summar
inform
collect
report
liu
et
al
report
strongli
suggest
appropri
vigil
program
well
involv
intern
regulatori
agenc
assess
benefit
herbal
medicin
screen
program
aim
identif
antihcv
medicin
plant
ongo
particularli
due
preval
infect
resourc
poor
countri
lack
good
vaccin
methanol
extract
acacia
nilotica
l
willd
ex
delil
boswellia
carterii
embelia
schimperi
quercu
infectoria
trachyspermum
ammi
l
aqueou
extract
piper
cubeba
l
q
infectoria
syzygium
aromaticum
l
show
potenti
inhibit
hcv
hussein
et
al
moreov
number
phytochem
product
catechin
glycyrrhizin
polysterol
silymarin
potenti
antihcv
agent
also
review
jassim
naji
patrick
emerg
viral
infect
pose
major
threat
mankind
medicin
plant
exhibit
broad
antivir
effect
could
brought
antivir
discoveri
program
infect
one
exampl
glycyrrhizin
bioactiv
compon
liquoric
glycyrrhiza
uralensi
fisch
lycorin
isol
lycori
radiata
l
initi
use
certain
indic
show
strong
antisarscov
activ
number
plant
previous
shown
possess
broadspectrum
antivir
effect
could
screen
newli
emergingresist
viral
strain
varieti
herbal
medicin
prepar
shown
potenti
inhibit
virus
caus
seriou
infect
among
human
measl
virus
olila
et
al
sindambiw
et
al
human
rotavirus
hrv
husson
et
al
takahashi
et
al
respiratori
syncyti
viru
rsv
human
rhinovirus
glatthaarsaalmul
et
al
coxsacki
group
virus
evstropov
et
al
su
et
al
neurotrop
sindbi
viru
nsv
pared
et
al
variou
strain
polioviru
andrighettifrohn
et
al
melo
et
al
vilagin
et
al
provedisprov
antivir
effect
herbal
prepar
essenti
molecularli
dissect
effect
studi
address
import
aspect
relev
therapeut
develop
phytochem
one
exampl
molecular
studi
hot
water
extract
stevia
rebaudiana
l
block
entri
variou
infecti
serotyp
hrv
permiss
cell
anion
polysaccharid
molecular
weight
uron
acid
major
sugar
constitu
takahashi
et
al
similarli
alkaloid
extract
haemanthu
albiflo
bulb
inhibit
rna
synthesi
hrv
propag
cell
husson
et
al
base
inform
fairli
conclud
medicin
plant
offer
varieti
antiinfecti
compound
particularli
antivir
agent
screen
program
aim
identifi
potenti
antiinfecti
agent
medicin
plant
offer
great
potenti
field
pharmaceut
develop
first
basic
step
toward
evalu
therapeut
potenti
medicin
plant
prepar
crude
cellular
lysat
plant
matrix
follow
extract
variou
compon
potenti
medicin
valu
sever
book
review
describ
standard
extract
procedur
medicin
plant
start
could
plant
drug
analysi
thin
layer
chromatographi
atla
wagner
et
al
modern
phytomedicin
turn
medicin
plant
drug
ahmad
et
al
laboratori
handbook
fraction
natur
extract
houghton
raman
book
publish
phytomedicin
mainli
paid
attent
classic
isol
procedur
unfortun
classic
procedur
limit
reproduc
qualiti
thu
compromis
safeti
efficaci
phytomedicin
prepar
urgent
need
refin
develop
classic
methodolog
obtain
procedur
consist
highli
pure
plant
compon
exhibit
medicin
valu
recent
past
increas
interest
tradit
medicin
complement
qualiti
awar
refin
extract
methodolog
standard
procedur
phytochemedicin
product
isol
attaurrahman
choudhari
ong
ensur
high
qualiti
herbal
prepar
effort
ongo
replac
tradit
methodolog
modern
sampl
prepar
extract
procedur
classic
solvent
separ
phytomedicin
product
complement
modern
techniqu
like
microwaveassist
extract
pressurizedliquid
extract
matrixassist
laser
desorptionion
mass
spectrometri
wu
et
al
sever
other
facilit
plantbas
drug
discoveri
effort
also
direct
toward
standard
methodolog
use
studi
pharmacokinespharmacodynam
behavior
phytomedicin
product
import
medicin
plant
ascertain
fact
accord
world
health
organ
estim
world
popul
fulfil
healthcar
need
phytomedicin
sourc
program
aim
inclus
medicin
plant
healthcar
need
peopl
sponsor
countri
plant
product
practic
medic
need
countri
heavi
usag
tradit
medicin
sponsor
scientif
program
devot
toward
modern
drug
discoveri
phytochem
improv
separ
technolog
offer
potenti
screen
medicin
plant
antiinfectiousantivir
natur
sever
problem
previous
thought
hurdl
medicin
plant
antivir
drug
discoveri
program
longer
issu
exampl
screen
antivir
potenti
plant
extract
alway
pose
threat
incident
infect
worker
vectorbas
assay
techniqu
help
overcom
screen
hurdl
ie
recombin
viral
vector
mimick
infect
express
firefli
luciferas
marker
gene
wide
use
screen
varieti
antivir
esimon
et
al
clever
usag
plant
product
vaccin
proteinbas
therapeut
sever
scientif
report
suggest
plant
could
offer
good
sourc
product
pharmaceut
grade
peptidesprotein
glenz
warzecha
koprowski
yusibov
sinc
express
first
subunit
vaccin
hbv
surfac
antigen
sever
differ
vaccin
antigen
success
express
plant
safeti
assess
anim
human
glenz
warzecha
et
al
thanavala
et
al
consid
aspect
plant
treat
human
viral
diseas
one
care
major
viral
vaccin
constitut
attenu
inactiv
viral
particl
due
limit
effort
direct
toward
express
coat
protein
differ
virus
presum
assembl
viruslikeparticl
vlp
plant
antigen
natur
sever
issu
like
appropri
process
protein
express
plant
import
aspect
consid
issu
resolv
translat
usag
medicin
plant
develop
world
one
issu
isol
activ
ingredi
associ
medicin
characterist
particular
plant
certain
part
world
crude
plant
extract
use
healthcar
efficaci
welldocu
without
side
effect
although
hard
get
plant
extract
approv
intern
regulatori
agenc
food
drug
administr
fda
unit
state
america
equival
european
counterpart
howev
countri
limit
resourc
govern
sponsor
explor
serv
gateway
merg
modern
drug
discoveri
convent
chineseeastern
medicin
moreov
consid
problem
face
develop
world
drug
resist
failur
find
effect
vaccin
deadli
infecti
agent
hiv
caus
agent
deadli
aid
phytomedicin
product
may
provid
hope
although
herbal
medicin
plant
prepar
wide
use
sever
part
world
individu
combin
data
interact
medicin
plant
live
system
nonexist
experi
indigen
peopl
use
particular
plantphytochem
product
treat
ailment
clinic
find
coadministr
medicin
plant
kavakava
st
john
wort
lead
hepatotox
musch
et
al
made
avail
healthcar
provid
practic
tradit
medicin
gener
herbal
remedi
perceiv
harmless
howev
sever
report
suggest
hepatotox
associ
herbal
medic
pak
et
al
schiano
public
scientif
report
relev
cytotox
medicin
plant
usag
encourag
incorpor
univers
databas
system
moreov
larger
random
doubleblind
placebocontrol
multicent
clinic
trial
conduct
incorpor
particular
herbal
remedi
treat
peopl
